1. Home
  2. MLTX vs LAUR Comparison

MLTX vs LAUR Comparison

Compare MLTX & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • LAUR
  • Stock Information
  • Founded
  • MLTX 2021
  • LAUR 1989
  • Country
  • MLTX Switzerland
  • LAUR United States
  • Employees
  • MLTX N/A
  • LAUR N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • LAUR Other Consumer Services
  • Sector
  • MLTX Health Care
  • LAUR Real Estate
  • Exchange
  • MLTX Nasdaq
  • LAUR Nasdaq
  • Market Cap
  • MLTX 2.3B
  • LAUR 2.9B
  • IPO Year
  • MLTX N/A
  • LAUR 2017
  • Fundamental
  • Price
  • MLTX $39.74
  • LAUR $22.74
  • Analyst Decision
  • MLTX Strong Buy
  • LAUR Buy
  • Analyst Count
  • MLTX 8
  • LAUR 2
  • Target Price
  • MLTX $80.50
  • LAUR $20.50
  • AVG Volume (30 Days)
  • MLTX 425.4K
  • LAUR 799.0K
  • Earning Date
  • MLTX 05-20-2025
  • LAUR 05-01-2025
  • Dividend Yield
  • MLTX N/A
  • LAUR N/A
  • EPS Growth
  • MLTX N/A
  • LAUR 143.51
  • EPS
  • MLTX N/A
  • LAUR 1.90
  • Revenue
  • MLTX N/A
  • LAUR $1,527,432,000.00
  • Revenue This Year
  • MLTX $103.42
  • LAUR $2.07
  • Revenue Next Year
  • MLTX N/A
  • LAUR $6.82
  • P/E Ratio
  • MLTX N/A
  • LAUR $12.05
  • Revenue Growth
  • MLTX N/A
  • LAUR 1.26
  • 52 Week Low
  • MLTX $31.42
  • LAUR $13.60
  • 52 Week High
  • MLTX $58.26
  • LAUR $23.05
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 51.51
  • LAUR 72.83
  • Support Level
  • MLTX $39.86
  • LAUR $19.71
  • Resistance Level
  • MLTX $42.90
  • LAUR $23.06
  • Average True Range (ATR)
  • MLTX 2.15
  • LAUR 0.64
  • MACD
  • MLTX 0.03
  • LAUR 0.36
  • Stochastic Oscillator
  • MLTX 48.60
  • LAUR 92.99

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About LAUR Laureate Education Inc.

Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.

Share on Social Networks: